| Date | Title | Description |
| 14.02.2026 | Biotech wins hearts – and funding | - |
| 15.10.2025 | OutcomesAI: $10 Million Seed Funding Closed For Expanding AI-Enabled Nursing Care Platform | OutcomesAI, a healthcare technology company developing AI-powered tools to enhance nursing capacity, announced it has raised $10 million in seed funding led by Santé Ventures. The Boston-based company is developing a new model of scalable n... |
| 14.12.2024 | Indonesia's Free Meal Program: A Recipe for Growth or a Recipe for Disaster? | Indonesia is stirring the pot with a bold initiative. On January 2, 2025, the government will launch a free meal program aimed at feeding 19.5 million schoolchildren and expectant mothers. This ambitious plan comes with a hefty price tag of... |
| 14.12.2024 | Doctor Anywhere's Workforce Reduction: A Strategic Shift in Telehealth | In the ever-evolving landscape of healthcare, change is the only constant. Doctor Anywhere, a prominent telehealth provider in Southeast Asia, recently announced a significant workforce reduction. The company has trimmed its staff by 8.1%, ... |
| 11.12.2024 | Singapore bets big on family office rules amid HK, Dubai rivalry | Premium Content
It takes our newsroom weeks - if not months - to investigate and produce stories for our premium content. You can’t find them anywhere else.
Tan Nai Lun · 1d ago · 5 min readSingapore bets big on family office rules amid HK,... |
| 10.12.2024 | Doctor Anywhere trims 8.1% workforce across Southeast Asia (update) | Premium Content
It takes our newsroom weeks - if not months - to investigate and produce stories for our premium content. You can’t find them anywhere else.
Renald Yeo · 12h ago · 2 min readDoctor Anywhere trims 8.1% workforce across Southe... |
| 10.12.2024 | Indonesia’s new meal program serves questions for alt-meat firms | Premium Content
It takes our newsroom weeks - if not months - to investigate and produce stories for our premium content. You can’t find them anywhere else.
Glenn Kaonang · 2d ago · 5 min readIndonesia’s new meal program serves questions fo... |
| 09.12.2024 | Can startups nurture Indonesia’s overlooked daycare market? | Premium Content
It takes our newsroom weeks - if not months - to investigate and produce stories for our premium content. You can’t find them anywhere else.
Glenn Kaonang · 2d ago · 5 min readCan startups nurture Indonesia’s overlooked dayc... |
| 09.12.2024 | Healthtech unicorn Biofourmis cuts more jobs after merger | Premium Content
It takes our newsroom weeks - if not months - to investigate and produce stories for our premium content. You can’t find them anywhere else.
Collin Furtado · 6h ago · 2 min readHealthtech unicorn Biofourmis cuts more jobs af... |
| 18.11.2024 | 5 New Unicorns Join The Board And 5 Exit In October | 2 Shares Email Facebook Twitter LinkedIn
Five companies joined The Crunchbase Unicorn Board in October 2024, across sectors spanning AI, energy, robotics, fintech and professional services. These five added over $7 billion in value to the b... |
| 29.10.2024 | The Rise of Atomberg and the Dawn of AI for SMEs | In the bustling world of startups, two companies stand out: Atomberg and PantherPulse. Each is carving its niche, but their paths are distinct. Atomberg is revolutionizing energy-efficient appliances, while PantherPulse is democratizing dat... |
| 25.10.2024 | PantherPulse uses AI to empower SMEs with data insights | Artificial IntelligenceStartups
Grace Priscilla Teo · 25 Oct 2024 · 2 min readPantherPulse uses AI to empower SMEs with data insights
This is Startup Spotlight, a series that features young, up-and-coming startups. Articles published here s... |
| 10.09.2024 | Improving Hospital Capacity Using Care-at-Home Strategies, Upcoming Webinar Hosted by Xtalks | www.biofourmis.com/care-delivery
In this free webinar, learn about the challenges faced by healthcare organizations, including inpatient capacity strain, resource constraints, increased hospital length of stay (LOS) and how these issues imp... |
| 02.08.2024 | Singapore to merge EDBI, SEEDS Capital to form SG Growth Capital | Singapore will merge two state-backed investment agencies, EDBI and SEEDS Capital, to form a new entity next year, according to an announcement on Friday.
EDBI, the investment arm of Singapore’s Economic Development Board (EDB), and SEEDS C... |
| 01.08.2024 | Digital Health Tools That Will Transform Cancer Treatment, Upcoming Webinar Hosted by Xtalks | www.biofourmis.com/life-sciences
In this free webinar, learn how clinical trials and care pathways are shifting to patients' homes — and oncology is no exception. Attendees will gain insights into how, despite clear benefits, incorporating ... |
| 28.07.2024 | CoachCare's $48 Million Investment: A Leap into the Future of Remote Patient Monitoring | In the ever-evolving landscape of healthcare, remote patient monitoring (RPM) is emerging as a beacon of hope. CoachCare, a New York-based company, has just secured a hefty $48 million in strategic growth investment. This funding, led by In... |
| 26.07.2024 | CoachCare raises $48M for RPM and virtual care monitoring platform | Photo: Jamie Grill/Getty Images
Remote patient monitoring and virtual care company CoachCare secured a $48 million strategic growth investment.
Integrity Growth Partners led the round with participation from Topmark Partners.
WHAT IT DOES
C... |
| 28.05.2024 | Unlocking Success: A Deep Dive into Delivering Acute Care at Home, Upcoming Webinar Hosted by Xtalks | www.biofourmis.com/care-delivery
In this free webinar, learn about the key considerations when growing a hospital-at-home program. Attendees will learn best practices for driving change management with staff. The featured speaker will share... |
| 14.03.2024 | GE HealthCare to Spotlight AI-Enabled Portfolio and Digital Solutions at HIMSS 2024 | Booth (#2500) will showcase AI-enabled innovations and digital solutions that enhance clinical decision making and provide personalized patient care
GE HealthCare will showcase its industry-leading portfolio of artificial intelligence (AI)-... |
| 03.03.2024 | 9 ViVE Announcements You Don’t Want to Miss | Healthcare conferences give executives the opportunity to convene and share ideas. They also give them the opportunity to announce news from their companies, oftentimes about new products, research or partnerships.
Below are nine noteworthy... |
| 26.02.2024 | GE HealthCare and Biofourmis partner on at-home care | GE HealthCare will use Biofourmis’ AI-guided algorithms to deliver personalized, at-home care
One of the lasting effects of the pandemic on the healthcare system was a shift to at-home care and remote patient monitoring. While the Mayo Clin... |
| 18.01.2024 | Biofourmis Launches In-Home Service Ecosystem to Transform Care Delivery | What You Should Know:
– Biofourmis, a global innovator in technology-enabled care delivery, today announced a groundbreaking move: the launch of its in-home service ecosystem.
– The platform empowers healthcare providers and biopharma compa... |
| 01.09.2023 | Biofourmis’ Founder Steps Down As CEO, Amidst Company Layoffs | Kuldeep Singh Rajput
What You Should Know:
– Biofourmis founder and CEO Kuldeep Singh Rajput has quietly resigned as CEO, according to the company’s spokesperson. The company has appointed private equity investor General Altantic’s Ben Wana... |
| 24.01.2023 | Orlando Health Selects Biofourmis to Enable Optimal Hospital-Level Care in Patients’ Homes | Biofourmis, a leading global technology-enabled care delivery provider, announced a multi-year agreement with Orlando Health, a non-profit healthcare organization that serves the southeastern United States. Orlando Health will leverage Biof... |
| 20.12.2022 | Amazon has only gotten started with its ambitions to be a serious player in healthcare. Here are 3 acquisitions it could make next year. | Amazon CEO Andy Jassy. Amazon has been building out its healthcare segment for the past few years, adding services from pharmacy to primary care. REUTERS/Mike Blake This story is available exclusively to Insider subscribers. Become an Insid... |
| 10.08.2022 | Intel Invests $20M in Biofourmis’ Virtual Care Offerings
| What You Should Know:
Founded in 2015, Biofourmis discovers, develops, and delivers clinically validated software-based therapeutics to provide better outcomes for patients, advanced tools for clinicians to deliver personalized care, techno... |
| 10.08.2022 | Biofourmis Raises Additional USD20M in Series D Financing; Brings Total Round to $320M | Biofourmis, a Boston, MA-based global leader in virtual care and digital medicine, raised an additional USD20m in Series D financing.
Intel Capital, the strategic investment arm of chipmaker Intel Corporation, joined its in an extension tha... |
| 10.08.2022 | Biofourmis scores another $20M and more digital health fundings | Photo: Kwanchai Lerttanapunyaporn/EyeEm/Getty Images |
| 27.07.2022 | [Updated] SG-founded healthtech unicorn Biofourmis raises $20m from Intel Capital | Editor’s Note: This story, first published on July 27, has been updated to include a company announcement from Aug 11.
Singapore-founded healthtech unicorn Biofourmis has raised $20 million from Intel Capital Corp, show regulatory filings a... |
| 18.07.2022 | Executive Roundtable: Can Innovation Alleviate Clinician Burnout? | The U.S. Surgeon General’s recent advisory about clinician burnout cited numerous societal, cultural, structural, and organizational causes—including excessive workloads, administrative burden, and lack of organizational support. The potent... |
| 27.04.2022 | Healthtech firm Biofourmis earns unicorn tag with $300m Series D round | Singapore-founded digital therapeutics firm Biofourmis announced raising $300 million in a Series D funding round led by growth equity firm General Atlantic, taking its valuation past the $1 billion mark. |
| 27.04.2022 | Biofourmis turns unicorn after snagging $300 mn in Series D round | AI-based healthtech startup, Biofourmis Singapore Pte Ltd said it has raised $300 million as part of its Series D funding round led by private equity firm General Atlantic, propelling the company into the much-coveted unicorn club.
ADVERTIS... |
| 27.04.2022 | Biofourmis picks up $300M Series D | Biofourmis has raised $300 million at more than $1 billion valuation in a round led by General Atlantic. The company's virtual healthcare platform is designed to monitor and manage chronic conditions such as heart failure, hypertension and ... |
| 26.04.2022 | MassMutual Ventures closes $300M fund to back Asia and Europe startups | MassMutual Ventures (MMV) has launched a $300 million new fund to back early-stage companies in Asia and Europe.
The MMV Asia and Europe team’s third vehicle will invest in startups across digital health, financial technology, enterprise Sa... |
| 26.04.2022 | Biofourmis raises $300 million as it looks to drive adoption of remote care | Biofourmis has spent years trying to figure out how to help care for patients with heart failure, cancer, and other debilitating diseases with the help of technology. Now, as it looks to scale, it must prove that it can deliver on its promi... |
| 26.04.2022 | Biofourmis Raises $300 Million in Round Led by General Atlantic | Biofourmis Inc., which seeks to use digital technologies to improve patient outcomes and help hospitals run more efficiently, has raised a $300 million growth financing that increases its valuation to $1.3 billion.
Growth-equity investor Ge... |
| 26.04.2022 | Biofourmis Secures $300M to Expand Virtual Care Offerings | Kuldeep Singh Rajput, Founder & Chief Executive Officer of Biofourmis
What You Should Know:
– Biofourmis, a global leader in virtual care and digital medicine raises $300 million in Series D investment led by leading global growth equit... |
| 26.04.2022 | Biofourmis reaches unicorn status with $300M Series D | Photo courtesy of Biofourmis |
| 26.04.2022 | Biofourmis Raises $300M Series D Financing |
BOSTON, MA, Biofourmis, a global leader in virtual care and digital medicine, today announced it has surpassed unicorn status with a $300 million Series D investment.
>> Click here for more funding data on Biofourmis
>> To e... |
| 25.04.2022 | Biofourmis turns unicorn after $300m series D | Artificial IntelligenceInvestmentsNewsStartups
Qishin Tariq · 2d ago · 1 min readBiofourmis turns unicorn after $300m series D
Medtech startup Biofourmis has joined the unicorn club, following a US$300 million series D funding round led by ... |
| 31.03.2022 | Powered by Biofourmis, Blessing Health System Partners Launches Home Hospital Services | What You Should Know:
– Blessing Health System, an integrated rural health system selects Biofourmis, a virtual care and digital therapeutics provider to launch its own home hospital services.
– As part of the selection, Biofourmis is suppo... |
| 04.12.2021 | The prestigious alumni of MedCity INVEST Pitch Perfect contest for healthcare startups | The healthcare startup landscape has transformed substantially in the past 10 years, fueled by robust investment, technology advances from immunotherapy to machine learning, changes in CMS reimbursement, and support from providers, payers, ... |
| 03.12.2020 | Biofourmis Announces National Rollout of the Biovitals® [email protected]™ Platform to Help Deliver Hospital-Level Care in the Home Aligned with New CMS Program | |
| 04.09.2020 | SoftBank Vision Fund 2 leads $100 million Series C in digital therapeutics company Biofourmis | As reported by Catherine Shu, TechCrunch (found here)
Biofourmis, which combines AI-based data analytics and biosensors to monitor the progress of medical treatments, has raised funding from one of the world’s most high-profile investors. ... |
| 03.09.2020 | [Funding alert] Biofourmis raises $100M in Series C round led by SoftBank Vision Fund 2 | US-based healthtech platform Biofourmis has today announced that it has raised $100 million in Series C funding round led by SoftBank Vision Fund 2. The round saw the participation of existing investors Openspace Ventures, MassMutual Ventur... |
| 03.09.2020 | Biofourmis Raises $100M for Its Digital Therapeutics Platform | Image: Shutterstock
Boston-based Biofourmis was one of the healthtech companies that was able to spring into action to help fight the COVID-19 pandemic. Back in early March, the company deployed hundreds of wearable sensors to people in Hon... |
| 03.09.2020 | Biofourmis Closes $100 Million Series C Funding Round Led by SoftBank Vision Fund 2 to Accelerate U.S. and Global Expansion | |
| 03.09.2020 | Biofourmis Lands $100M to Expand AI-Powered Digital Therapeutics Platform | What You Should Know:
– Boston-based digital therapeutics leader Biofourmis just closed a $100 million Series C funding round led by SoftBank, bringing its total funding to $145M.
– Biofourmis will be using the funding to develop, validate ... |
| 03.09.2020 | SG’s Biofourmis snags $100m led by SoftBank Vision Fund 2 | Premium
Singapore-based health analytics platform Biofourmis has raised $100 million in a Series C financing round led by SoftBank Vision Fund 2, per an announcement.
Continue reading this story with a subscription to DealStreetAsia.
Subscr... |
| 03.09.2020 | Singapore based digital therapeutics firm Biofourmis raises US$ 100M | - |
| 03.09.2020 | SoftBank leads $100M investment for intelligent health monitoring and digital therapeutics startup Biofourmis | |
| 03.09.2020 | Healthcare startup Biofourmis closes $100 million SoftBank Vision Fund 2-led round | TOKYO: Healthtech startup Biofourmis said on Thursday it has closed a $100 million series C funding round led by SoftBank Group Corp's Vision Fund 2, as the Japanese firm extends its bets on a sector growing through the coronavirus outbreak... |
| 03.09.2020 | Softbank leads $100M investment in remote monitoring startup Biofourmis | The goal was to reduce hospital readmissions and emergency-room visits for patients taking Novartis’ heart failure medication, Entresto. By catching early signs of deterioration, physicians could intervene sooner.
Heart failure patients wer... |
| 03.09.2020 | Biofourmis raises $100 million in Series C round | Boston-headquartered Biofourmis Holdings Pte Ltd, a digital therapeutics firm, has raised $100 million in Series C round led by SoftBank’s Vision Fund 2, with the participation from existing investors, Openspace Ventures, MassMutual Venture... |
| 03.09.2020 | Biofourmis Raises $100 Mn In Series C Round Led By SoftBank | September 3, 2020 2 min read
Biofourmis, an Asia-born global leader in digital therapeutics on Thursday announced that it has raised $100 million in Series C round led by Softbank Vision Fund 2. Existing investors such as Openspace Ventures... |
| 03.09.2020 | Biofourmis raises $100 million for remote patient monitoring tools | Biofourmis, a Boston startup that makes technology to remotely monitor patients with chronic conditions and dangerous diagnoses, announced Thursday that it has taken in $100 million in new investment to help it advance products in the field... |
| 03.09.2020 | Biofourmis raises $100 million funding led by SoftBank Vision Fund 2 | Health-tech company Biofourmis on September 3 said it has raised $100 million (about Rs 733.7 crore) in funding led by SoftBank Vision Fund 2. The series C round also saw participation by existing investors Openspace Ventures, MassMutual Ve... |
| 03.09.2020 | Biofourmis bags USD 100 million in Series C round led by SoftBank | Singapore-founded healthtech startup Biofourmis on Thursday announced that it closed a USD 100 million Series C round led by SoftBank Vision Fund 2. The investment nearly triples the firm’s valuation to USD 700 million, according to Bloombe... |
| 03.09.2020 | Biofourmis Scoops Up $100M Series C Round |
BOSTON, MA, Biofourmis, a fast-growing global leader in digital therapeutics that powers personalized predictive care, has announced the completion of a $100 million Series C round.
>> Click here for more funding data on Biofourmis... |
| 03.09.2020 | Healthcare startup Biofourmis closes $100 million SoftBank Vision Fund 2-led round | By Sam Nussey
TOKYO (Reuters) - Healthtech startup Biofourmis said on Thursday it has closed a $100 million series C funding round led by SoftBank Group Corp's Vision Fund 2, as the Japanese firm extends its bets on a sector growing through... |
| 03.09.2020 | Biofourmis Closes $100 Million Series C | Biofourmis, a fast-growing global leader in digital therapeutics that powers personalized predictive care, has announced the completion of a $100 million Series C financing round led by SoftBank Vision Fund 2,[1] with participation by exist... |
| 03.09.2020 | Biofourmis Closes $100M Series C Funding | Biofourmis, a Boston, MA-based developer of digital therapeutics for personalized predictive care, completed a $100m Series C financing.
The round was led by SoftBank Vision Fund with participation from existing investors Openspace Ventures... |
| 02.09.2020 | Biofourmis raises $100 million for AI remote medical tools | Biofourmis, an AI health IT company based in Boston, today announced it raised $100 million in a series C funding round led by SoftBank’s Vision Fund 2. CEO Kuldeep Singh Rajput said the company will use the proceeds to accelerate expansion... |
| 02.09.2020 | Biofourmis raises $100 million for AI remote medical tools | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
Biofourmis, an AI health IT company based in Boston, today announced it raised $100 million in a series C funding round led by SoftBank... |
| 02.09.2020 | SoftBank Vision Fund 2 leads $100 million Series C in digital therapeutics company Biofourmis | Biofourmis, which combines AI-based data analytics and biosensors to monitor the progress of medical treatments, has raised funding from one of the world’s most high-profile investors. The digital therapeutics company, which launched in Sin... |
| 04.10.2019 | Biofourmis Analytics Engine Receives FDA Clearance for Ambulatory Physiologic Monitoring | – Biofourmis received 510(k) clearance from the FDA for its Analytics Engine as a medical device for ambulatory physiological monitoring.
– Milestone approval establishes an AI-powered solution as the foundation for future disease-specific ... |
| 17.07.2019 | Yale, Mayo Clinic, Biofourmis Launches Research to Detect Heart Failure Using Wearable Biosensor Data | Biofourmis has entered a research partnership with the Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI). Biofourmis’ mobile platform BiovitalsHFTM will be leveraged in a study of patients with he... |
| 22.05.2019 | Sequoia leads $35 million round in digital therapeutics startup Biofourmis | BENGALURU: Sequoia Capital India has led a $35 million round in four year old digital therapeutics startup Biofourmis along with US-based MassMutual Ventures. The investment will take the total capital raised by Singapore-based startup to $... |
| 22.05.2019 | Term Sheet — Wednesday, May 22 | STAYING PRIVATE
“Why would we go public?”
Paid Content You can't secure what you can't see From ExtraHop
TransferWise, which offers a cross-border money transfer service, announced a new $292 million secondary round that values the company ... |
| 22.05.2019 | Biofourmis Raises $35M | Digital healthtech startup Biofourmis Biofourmis
Founded: 2015
Headquarters: Boston, MA, US
Total Funding: $143.57M
See full company profile "> has raised $35m in a Series B round from Sequoia India, MassMutual Ventures, Openspace V... |
| 22.05.2019 | Biofourmis raises $35M to support AI-based digital therapeutics for chronic disease | By the end of 2019, the company plans to have a workforce of more than 100 employees split across Boston and Singapore.
“Sequoia India is excited to lead this round investing in Biofourmis, an innovative health tech start-up with the potent... |
| 22.05.2019 | Sequoia leads $35 mn round in Biofourmis | Biofourmis chief executive officer Kuldeep Singh Rajput. Sequoia leads $35 mn round in Biofourmis 2 min read . Updated: 22 May 2019, 10:20 PM IST M. Sriram
Firm to use funds to expand commercialization efforts in US, Asia
The investment in ... |
| 22.05.2019 | Biofourmis raises $35M to develop smarter treatments for chronic diseases | As reported by Jon Russell in TechCrunch (found here):
Biofourmis, a Singapore-based startup pioneering a distinctly tech-based approach to the treatment of chronic conditions, has raised a $35 million Series B round for expansion.
The ro... |
| 21.05.2019 | Biofourmis Closes $35 Million Series B | Biofourmis, a fast-growing leader in digital therapeutics, today announced that it has successfully closed $35 million in Series B financing. The company also announced it will be expanding its Boston office and moving its headquarters from... |
| 21.05.2019 | AI-enabled monitoring, decision support platform Biofourmis raises $35M | |
| 21.05.2019 | Biofourmis raises $35M to develop smarter treatments for chronic diseases | Biofourmis, a Singapore-based startup pioneering a distinctly tech-based approach to the treatment of chronic conditions, has raised a $35 million Series B round for expansion.
The round was led by Sequoia India and MassMutual Ventures, the... |
| 21.05.2019 | Biofourmis Closes $35M Series B Financing Round | Biofourmis, a Boston, MA-based digital therapeutics company, closed $35m in Series B financing.
The round was led by Sequoia India, and co-led by MassMutual Ventures, with participation from EDBI and Jianke and existing investors Openspace ... |
| 21.05.2019 | Biofourmis raises $35 million to create digital health ‘biomarkers’ with AI | Biofourmis, an AI health IT company based in Singapore, today announced that it’s raised $35 million in a series B financing round led by Sequoia Capital’s Sequoia India and MassMutual Ventures, with participation from Singapore government-... |
| 21.05.2019 | Biofourmis Lands $35M for AI-Powered Digital Therapeutics Platform | Biofourmis, a Boston, MA-based digital therapeutics platform, today announced that it has raised $35 million in Series B funding led by Sequoia Capital/Sequoia India and co-led by Mass Mutual. The latest funding round will enable the compan... |
| 21.05.2019 | Daily funding roundup - May 21st, 2019 | Silo raised $3M; Impossible Objects secured $4.1M; Mightier landed $6.6M; Fullbay secured $23M
Silo: Silo is a technology-driven marketplace that uses AI to streamline supply chains for perishable agribusiness. Silo has raised $3 million se... |
| 21.05.2019 | Biofourmis Closes $35 Million Series B | Biofourmis, a fast-growing leader in digital therapeutics, today announced that it has successfully closed $35 million in Series B financing. The company also announced it will be expanding its Boston office and moving its headquarters from... |
| 21.05.2019 | Singapore’s Biofourmis secures $35m Series B funding co-led by Sequoia India | Premium
Singapore-based health analytics platform Biofourmis has raised a Series B financing round of $35 million led by Sequoia India and MassMutual Ventures SEA, the venture fund of Massachusetts Mutual Life Insurance Company.
Continue re... |
| 08.08.2018 | Pain management solution with Swiss wearable technology | |
| 13.12.2017 | NSI Ventures hits first close on new $125M fund for Southeast Asia | There’s been pause since Southeast Asia last welcomed fresh venture capital, but one reload is on its way after NSI Ventures, an early investor in Indonesian unicorn and Uber rival Go-Jek, announced a first close of its second fund. The tar... |
| 12.12.2017 | Biofourmis Raises US$5.0M in Series A Financing | Biofourmis, a Singapore-based digital healthtech company, raised US$5.0m in Series A funding.
Backers included NSI Ventures and Aviva Ventures, the strategic corporate venture arm of international insurer, Aviva plc.
The company intends to ... |
| 11.12.2017 | Singapore: Biofourmis raises $5m Series A from NSI Ventures, Aviva Ventures | Premium
Singapore-based health analytics platform Biofourmis has closed a $5-million Series A round from NSI Ventures and Aviva Ventures, in addition to securing a partnership with US-based Mayo Clinic.
Continue reading this story with a su... |
| - | Biofourmis raises $35M to support AI-based digital therapeutics for chronic disease | Singaporean startup Biofourmis has raised a $35 million Series B financing round led by to support the growth and commercialization of its digital therapeutics platform and support hiring as the startup moves to its new Boston headquarters.... |
| - | Biofourmis | “Biofourmis partners with healthcare organizations and life science companies to provide solutions that help expand the delivery of care to everyone, everywhere.” |
| - | The prestigious alumni of MedCity INVEST Pitch Perfect contest for healthcare startups | The healthcare startup landscape has transformed substantially in the past 10 years, fueled by robust investment, technology advances from immunotherapy to machine learning, changes in CMS reimbursement, and support from providers, payers, ... |
| - | Softbank leads $100M investment in remote monitoring startup Biofourmis | A healthcare provider logs into Biofourmis’ platform. The company uses remote monitoring devices to track how heart failure patients fare after they are discharged from the hospital. Photo credit: Biofourmis
Since it first struck a partners... |
| - | Biofourmis | “Vital innovations that bring the right care to every person, everywhere Our technology platform reads 120+ patient biomarkers to build precise insights and proactive interventions. 93% 70% accurate in predicting clinical deterioration redu... |
| - | Price transparency, virtual care and timely access to data take on many forms at ViVE 2022 | This article is part of a series powered by HLTH and CHIME to highlight key insights and perspectives from leading executives speaking at ViVE.
StartUp Health co-founder Unity Stoakes announced a few milestones at ViVE this week. The startu... |
